A citation-based method for searching scientific literature

P Zanos, T D Gould. Mol Psychiatry 2018
Times Cited: 313



Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez, Alan F Schatzberg. Am J Psychiatry 2018
Times Cited: 205




List of shared articles



Times cited

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial).
Bronagh Gallagher, Meabh Foley, Claire M Slattery, Gabriele Gusciute, Enda Shanahan, Declan M McLoughlin. HRB Open Res 2022
0

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.
Ya-Ting Wang, Ning-Ning Zhang, Ling-Jie Liu, Hong Jiang, Die Hu, Zhen-Zhen Wang, Nai-Hong Chen, Yi Zhang. Biochem Biophys Res Commun 2022
0

Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers.
Ellen Scotton, Bárbara Antqueviezc, Mailton França de Vasconcelos, Giovana Dalpiaz, Luiza Paul Géa, Jéferson Ferraz Goularte, Rafael Colombo, Adriane Ribeiro Rosa. Biochem Pharmacol 2022
0

Ketamine treatment for depression: a review.
Mani Yavi, Holim Lee, Ioline D Henter, Lawrence T Park, Carlos A Zarate. Discov Ment Health 2022
0

Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2.
Juan Pablo Lopez, Malte D Lücken, Elena Brivio, Stoyo Karamihalev, Aron Kos, Carlo De Donno, Asaf Benjamin, Huanqing Yang, Alec L W Dick, Rainer Stoffel,[...]. Neuron 2022
0


Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.
Danilo De Gregorio, Argel Aguilar-Valles, Katrin H Preller, Boris Dov Heifets, Meghan Hibicke, Jennifer Mitchell, Gabriella Gobbi. J Neurosci 2021
24